Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix, Inc. - Common Stock (NQ: CMRX )

8.460 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 8.410 (268)
Ask (Size) 8.430 (20)
Prev. Close 8.460
Today's Range 8.460 - 8.460
52wk Range 0.7500 - 8.470
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here are the top movers in Wednesday's session.
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
These stocks are making the most noise in today's session.
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill

Performance

YTD
+149.56%
+149.56%
1 Month
+122.63%
+122.63%
3 Month
+872.53%
+872.53%
6 Month
+845.99%
+845.99%
1 Year
+599.17%
+599.17%

More News

Read More
Demystifying Chimerix: Insights From 4 Analyst Reviews
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, IVAC, BRDG on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Chimerix Through 4 Analysts
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Chimerix, Inc. (Nasdaq - CMRX), Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Intevac, Inc. (Nasdaq - IVAC)
From Brodsky & Smith LLC
Via GlobeNewswire
Wednesday's session: gap up and gap down stocks
Via Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
Via Benzinga
CMRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chimerix, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
From Chimerix, Inc.; Jazz Pharmaceuticals plc
Via GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Chimerix, Inc.
Via GlobeNewswire
Chimerix to Speak Today at The White House Cancer Moonshot Forum
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
From Chimerix, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings
Via Benzinga
Dow Falls 150 Points; Oracle Posts Downbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday?
Via Benzinga
Exposures Product Safety
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
From Chimerix, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.